Artiva Biotherapeutics, Inc. Common Stock (ARTV) — Long-term Investment Intensity

Latest as of September 2024: 23.5%

Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Long-term Investment Intensity of 23.5% as of September 2024. Long-term investments of $52.97 Million represent 23.5% of total assets of $225.60 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ARTV total equity for net asset value and shareholders' equity analysis.

LT Investment Intensity

23.5%
LT Investments / Total Assets

Long-term Investments

$52.97 Million
USD

Total Assets

$225.60 Million
USD

Country

USA
NASDAQ

Annual Long-term Investment Intensity for Artiva Biotherapeutics, Inc. Common Stock (None–None)

The table below presents the year-by-year Long-term Investment Intensity for Artiva Biotherapeutics, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ARTV stock market capitalisation.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
pp = percentage points